Second Line of Defense Against RAdailyRxRituximab for rheumatoid arthritis better choice when first round of TNF inhibitors fail. People with rheumatoid arthritis are often treated with anti-TNF drugs. When these drugs fail, patients may need to switch…
R-CHOP benefits older mantle-cell lymphoma patientsMedical XpressIn older patients with mantle-cell lymphoma, a rituximab-based chemotherapy regimen (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) followed by maintenance therapy…
R-CHOP Benefits Older Mantle-Cell Lymphoma PatientsJournal of the American Academy of Physician Assistants(HealthDay News) – In older patients with mantle-cell lymphoma, a rituximab-based chemotherapy regimen (rituximab, cyclophosphamide, doxorubicin…
Rituximab Works for Older Mantle Cell PatientsMedPage TodayThe long-term prognosis for older patients with mantle cell lymphoma is poor. This study evaluated the results of patients 60 years of age or older with mantle cell lymphoma, randomly assigned …
Rituxan May Help With Kidney DisorderdailyRxIdiopathic membranous nephropathy patients taking rituximab experienced remission. While medications can help people with kidney problems, they are no magic bullet. In some cases, the drugs used to treat kidn…
Pharmacyclics' fifth patient enrollment in phase III Resonate study triggers …pharmabiz.comThese studies include: phase III combination study of bendamustine/rituximab plus ibrutinib versus bendamustine/rituximab plus placebo in relapsed or refra…
Spectrum Pharmaceuticals Announces Publication in the Journal of Clinical …Business Wire (press release)The ZEVALIN therapeutic regimen consists of two components: rituximab, and Yttrium-90 (Y-90) radiolabeled ZEVALIN for therapy. ZEVALIN builds on t…
Spectrum Pharmaceuticals Announces Publication in the Journal of Clinical …eYugoslavia.com… the journal of the American Society of Clinical Oncology, showed that first-line consolidation with ZEVALIN treatment regimen, following initial therapy con…
SPECTRUM PHARMACEUTICALS, INC. : Spectrum Pharmaceuticals …4-tradersThe ZEVALIN therapeutic regimen consists of two components: rituximab, and Yttrium-90 (Y-90) radiolabeled ZEVALIN for therapy. ZEVALIN builds on the combined effect of a targeted bio…
Spectrum Pharmaceuticals Announces Publication in the Journal of Clinical …MarketWatch (press release)The ZEVALIN therapeutic regimen consists of two components: rituximab, and Yttrium-90 (Y-90) radiolabeled ZEVALIN for therapy. ZEVALIN builds on the…